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The present study examined the mRNA levels of glucose transporter Glut4 and G-protein G, a-subunit in isolated ventricular myocytes from lean 
and genetically obese (/&“a) Zucker rats and streptozotocin-diabetic rats. In obese animals the amount of transcripts coding for Glut4 increased 
to 122+6% of lean controls, whereas the mRNA coding for G, or-subunit decreased by 42& 12%. An unaltered level of G, mRNA was observed 
in insulin deficient rats. When cardiomyocytes from normal rats were treated with insulin, the Glut4 transcript level increased by 48&S%&, whereas 
the G, mRNA level decreased by 55 + 8%. The findings suggest that insulin may act as a potential regulator of Glut4 and G, mRNA expression 
in the cardiac cell. 
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1. INTRODUCTION 
shown to be associated with 
of gene expression at both the 
whereas hepatocytes from obese Zucker rats exhibited a 
reduction in G, a-subunit expression [16]. 
Diabetes has been 
substantial alterations 
This laboratory has recently reported a large decrease 
in Glut4 mRNA expression in cardiomyocytes from 
streptozotocin-diabetic rats 1121. Furthermore, a func- 
tional association of Glut4 and a cholera-toxin-sensitive 
G-protein has been delineated [12]. In order to gain in- 
itial insights into the complex relationship between 
Glut4 and G-protein expression in diabetes, we have 
now performed the simultaneous determination of 
Glu’t4 and G, m-subunit mRNA levels in ventricular 
myocytes from insulin resistant rats. The data suggest 
an inverse regulation of Glut4 and G, mRNA expres- 
sion by insulin. 
protein and mRNA levels [1,2]. Several affected genes 
are thought to be of major importance for the patho- 
genesis of insulin resistance and these include the in- 
sulin responsive glucose transporter Glut4 [3-51 and the 
guanine nucleotide-binding proteins (G-proteins) [6,7]. 
Glut4 is exclusively expressed in fat and muscle and is 
responsible for the major part of insulin stimulated 
glucose uptake in these tissues [8,9]. On the other hand, 
G-proteins are known to couple many receptors to their 
effector systems and increasing evidence suggests that 
G-proteins are also involved in cellular signalling by in- 
sulin [IO-121. 
The relative contributions of altered Glut4 and G- 
protein expression to the insulin resistant state are 
presently unknown. FurtherInore, tissue specific dif- 
ferences and differences between insulin-deficient 
diabetes and insulin resistance of obesity and Type II- 
diabetes have to be considered. Thus, in adipocytes [4] 
and skeletal muscle [3] of steptozotocin-diabetic rats 
the mRNA level of Glut4 was reported to be largely 
reduced. In contrast, no changes in the mRNA coding 
for G-protein a-subunits were observed in brain, mus- 
cle or kidney, whereas a significant reduction was 
detected in hepatocytes from insulin-deficient rats [ 131. 
In skeletal muscle of obese Zucker rats [14] and ob/ob 
mice [15] the level of Glut4 protein was unchanged, 
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2. MATERIALS AND METI-IODS 
2.1. Chemicals 
[y-32P]ATP (spec. radioact. 6000 CVmmol) and the CL a-subunit 
oligonucleotide probe were purchased from New England Nuclear, 
Dreieich, Germany. Collagenase (EC 3.4.24.3) was from Serva, 
Heidelberg, Germany. The Glut4 oligonucleotide probe was syn- 
thesized by Promega, Madison, WI. USA. All other chemicals were 
analytical grade and supplied by Merck, Darmstadt, Germany. 
2.2. Animals 
Male Wistar rats fed ad libitum and weighing 280-320 g were used 
for the preparation of normal cardiomyocytes. Insulin-deficient 
diabetes was induced as described [17] by injecting citrate-buffered 
streptozotocin at a dosage of 60 mg/kg body wt., i.p. Genetically 
obese (fa/fa) male Zucker rats (12-16 weeks old) and their age- 
matched lean controls (FA/?) were bred in the animal laboratories of 
the Diabetes Research Institute. Blood samples were collected from 
the vena renalis immediately before starting perfusion of the hearts 
and taken for analysis of plasma glucose and insuliil as previously 
described [18,19]. 
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2.3. Isolation of heart cells 
Calcium-tolerant myocytes were isolated by perfusion of the heart 
with collagenase as described in detail previously [ZOI. The final cell 
suspension was washed three times with HEPES buffer (composition 
NaCl 130 mM, KC1 4.8 mM, KHzPO4 1.2 mM, HEPES 25 mM, 
.fducose 5 mM, BSA 20 g/l, pH 7.4, equilibrated with Or) and in- 
cubated at 37°C. CaClr and M.g!Q (final cont. 1 mM) were added 
and incubation was continued until further use. 
2.4. RNA isolation and Northern-blot analysis 
Tota! cellular RNA was isolated from ventricular myocytes by the 
guanidinium thiocyanate/phenol/chloroform method 1211, separated 
by electrophoresis and transferred to nylon membranes as described 
1121. Densitometry of ethidium bromide-stained 18 S rRNA was used 
to normalize the amount of RNA loaded per lane. Blots were 
hybridized to oligonucleotide probes which were 5’-end-labelled to a 
specific radioac:ivity of (2-6) x 10’ dpm/pg by using [3ZP]ATP and 
T4 kinase. After washing under low-(G,) and high-stringency (Glut4) 
conditions, the blots were exposed to Kodak X-Omat AR film at 
-7O’C by using intensifying screens. The autoradiographs were 
quantified by laser-scanning densitometry to determine the relative 
amounts of Glut4 and GI mRNA. Multiple scans were made of each 
band and the results averaged. Samples from control and diabetic 
tissues were always run on the same blots, since the present method 
is valid only when comparing different samples analyzed in the same 
blot. Significance of reported differences was evaluated by using t 
statistics for paired and unpaired data. 
3. RESULTS 
All experiments were performed on ventricular car- 
diomyocytes isolated from normal Wistar rats, from 
low-dose streptozotocin-diabetic rats (blood glucose 
30 f 1 mIW versus 6k 0.2 mM in controls; plasma in- 
kb 
3.23 _ 
2.86 - 
kb 
-a 2.72 
sulin 7.OkO.9 pIJ/ml versus 21.73z3.5 fiU/ml in con- 
trols) and from lean and obese Zucker rats (normogly- 
cemic; plasma insulin 525 f 198 ~U/rnl versus 27 f 5 
PI-J/ml in lean animals). As described in earlier reports 
from this laboratory [ 17,181, rnyocytes from diabetic 
animals were found to have an unaltered morphology, 
viability (go-90%) and ATP-content. The different 
groups of animals exhibited an unaltered yield of total 
RNA, which varied between 40-60 ,zg/106 cells. 
The effect of obesity on glucose transporter expres- 
sion was examined by probing Northern blots of total 
RNA from lean and obese Zucker rats with a 24mer 
oligonucleotide specific to Glut4 [12]. As shown in Fig. 
1, a major transcript of 2.7 kb for both lean and obese 
rats was identified, Densitometric analysis of auto- 
radiograms revealed a slight (122*6% of control) but 
significant increase in Glut4 mRNA concentration. 
When the same analysis was performed using an 
oligonucleotide probe against the G, a-subunit mRNA 
(constructed against position 580-618 [22J), one single 
transcript of 1.9 kb was observed which was reduced by 
42 + 12% in myocytes from obese Zucker rats (Fig. 2, 
left panel). In contrast, an unaltered G, a-subunit 
mRNA level has been quantified in cardiomyocytes 
from insulin deficient rats (Fig. 2, right panel). This is 
completely different from the large decrease in Glut4 
expression in heart myocytes from these animals [12]. 
Inverse regulation of Glut4 and G, mRNA expression 
could be related to the high plasma insulin levels of 
Pig. 1. Northern-blot analysis of Glut4 mRNA expressed in cardiac myocytes from lean (L) and obese (0) Zucker rats. (A) Total RNA was e!ec- 
trophoresed (10 p&lane), transferred to a nylon membrane and hybridized with a ‘*P-labelled oligonucleotide probe complementary to Glut4. 
Autoradiograms were exposed for 2 days. The position of RNA size markers is indicated on the left. (B) mRNA was quantified from 
autoradiograms by laser-scanning densitometry relative to the amounts in controls, which was assigned a value of 1 .O. Data are means + SE (n = 3). 
‘Significantly different from lean control (P= 0.034) 
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Fig. 2. Detection of mRNA encoding the Gs a-subunit in cardiac 
myocytes from diabetic rats. L, lean Zucker rat; 0, obese Zucker rat; 
C, control; S, streptozotocin-diabetes. Upper panel: 5 cg of total 
RNA per lane. Blots were hybridized with a radiolabelled 
oligonucleotide probe complementary to 0, a-subunit. Exposure time 
was 6 days, Lower panel: Quantification of mRNA was performed as 
outlined in Fig. 1. Data are means -+ SE (r/=4). ‘Significantly dif- 
ferent from lean control (P= 0.048) 
obese Zucker rats. Therefore, cardiac myocytes from 
normal Wistar rats were incubated with the hormone 
for 4 hours and processed for Northern-blot analysis of 
total RNA. Under these conditions the mRNA level of 
Glut4 was increased by 48+5%, whereas the G, a- 
subunit mRNA level decreased by 55 -cB% (Fig. 3). 
Isoproterenol had no effect on the transcript concentra- 
tions of both Glut4 and G, a-subunit. 
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Fig. 3. Effect of insulin and isoproterenol on the levels of Glut4 (left 
panel) and G, cu-subunit (right panel) mRNA in isolated cardiac 
myocytes. Cells were incubated for 4 h at 37’C in the absence (con- 
trol) or presence of insulin (10h6 M) or isoproterenol (10v4 M). Each 
lane contains 10 fig total RNA. Hybridization and quantification of 
mRNA were performed as outlined in Figs. 1 and 2. Data are 
means k SE (n = 3-5). Significantly different from control 
‘(P= O.OOS), “(P=O.O02). 
4. DISCUSSION 
Reduced Glut4 expression most probably contributes 
to the pathogenesis of insulin resistance in insulin- 
deficient diabetes and has been observed in all target 
tissues [3-5,121. A more complex situation and an ap- 
parent difference between fat and muscIe may be found 
in other states of insulin resistance like obesity and Type 
II-diabetes. Thus, a large decrease in Glut4 gene expres- 
sion detected in adipocytes from patients with obesity or 
NIDDM [23] contrasts with an unaltered Glut4 expres- 
sion in skeletal muscle of such patients [24]. Our results 
now show that Glut4 mRNA expression even slightly in- 
creases in cardiac muscle From obese Zucker rats. This 
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finding agrees in principle with recent reports of an 
unaltered Glut4 expression in skeletal muscle of obese 
mice [ 15,251 and Zucker rats [14], and supports the no- 
tion that Glut4 exrvession is regulated in a tissue- 
specific way [25,26J. 
This laboratory has recently reported the existence of 
both receptor and postreceptor-defects when character- 
izing the resistance of insulin stimulated glucose uptake 
in cardiomyocytes from obese Zucker rats [18]. Basal 
transport and maximal responsiveness were largely 
reduced in agreement with observations in the perfused 
heart [2’r]. The present study shows that this defect is 
accompanied by an increase in Glut4 mRNA expression 
and therefore suggests that the defect in glucose 
transport may be related to changes in intrinsic activity 
or translocation of Glut4 or to altered transmembrane 
signal!ling by insulin. 
In contrast to Glut4, a substantial reduction in the 
mRNA coding for Gs a-subunit was observed in car- 
diomyocytes from obese rats, whereas an unaltered 
level was determined in streptozotocin-diabetic rats. 
The latter finding agrees well with a recent report by 
Griffiths et al. [ 131, who described an unaltered expres- 
sion of G, ct+subunit mRNA in the streptozotocin- 
diabetic rat heart. The functional implications of reduc- 
ed G, mRNA expression in obesity remain to be 
elucidated. It has been proposed that G, may interact 
with the glucose transporter [28] and it may be 
speculated that reduced expression of G, is related to 
the defect in cardiac glucose transport. This issue needs 
further irivestigation. 
The inverse regulation of Glut4 and 6, mRNA ex- 
pression observed in obese Zucker rats could be com- 
pletely mimicked by incubating cardiomyocytes from 
normal rats with insulin for 4 h, suggesting that the high 
plasma insulin levels might be responsible for altered 
gene expression. Indeed, insulin has been implicated in 
Glut4 gene expression [29], although tissue specific dif- 
ferences seem to be involved. Thus, in L6 muscle cells 
[29] Glut4 mRNA expression was decreased by prolong- 
ed administration of insulin. On the other hand, in 
hyperinsulinemic rats [30] Glut4 mRNA increa.sed in 
adipose tissue but decreased in skeletal muscle. In con- 
trast to Glut4, hormone responsive elements have 
already been identified in the 5 ’ non-coding region of 
G-protein a-subunit genes [31] and regl;lation of G- 
protein expression by steroids [32] and thyroid hor- 
mones [33] has been reported. To our knowledge, the 
present study is the first report of a direct effect of in- 
sulin on G-protein mRNA expression. Thus, in addition 
to signalling via G-proteins [12], insulin may regulate 
the level of these signal transducing elements. 
Taken together, reciprocal changes of Glut4 and GS 
a-subunit rnRNA levels have been observed in car- 
diomyocytes from obese rats. The data suggest hat in- 
sulin may act as a potential regulator of Glut4 and G, 
mRNA expression in the cardiac cell. 
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